萊爾科技(688683.SH):對萊特爾實施吸收合併已完成相關審批程序
格隆匯7月8日丨萊爾科技(688683.SH)公佈,公司於2021年4月27召開第二屆董事會第五次會議、於2021年5月18日召開2020年年度股東大會審議通過了《關於公司吸收合併全資子公司的議案》,公司擬吸收合併全資子公司廣東順德萊特爾科技有限公司(“萊特爾”)。
吸收合併完成後,萊爾科技作為吸收方存續,萊特爾作為被吸收方,其全部資產、負債、權益以及人員由萊爾科技承接,其獨立法人資格將被註銷,存續後的萊爾科技註冊資本為1.4856億元。
公司此次對全資子公司萊特爾實施吸收合併已完成公司及萊特爾內部相應的審批程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.